University of British Columbia professor says Health Canada should be more compatible with other countries when it comes to the issue of the safety risk prevention of certain medications, especially when other countries have advised patients taking the same drugs.
Barbara Mintzes with & # 39 is the lead researcher of the new study and says that between 2007 and 2016, Health Canada issued a safety warning only 50 percent of drug safety issues identified in the United States, Australia and the UK.
She joined the researchers in analyzing the 1441 recommendation during this period and found the controls in all four countries were consistent only in the decision to warn their population 10 percent of the time in relation to matters with the same drug.
Associate professor in the UBC School branch in the field of population and public health also urges Health Canada to be more transparent in providing patient information readily available on the Internet about the adverse reactions with various medications.
Health Canada did not immediately respond to a request for comment.
The study is published in JAMA Internal Medicine, published by the American Medical Association, and also includes studies at York University in Toronto and the University of Sydney in Australia.
Like us on Facebook and follow us on twitter